Employing a Biomarker-Driven Approach to Depression with Selection Based on Neuroendocrine Changes
Time: 1:30 pm
day: Track 2: Translational & Clinical
Details:
- Showcasing a precision medicine study of ANC-501 for MDD
- Outlining the rationale for harnessing biomarker-driven stress hormone system disruptions
- Next steps for advancing the precision medicine study into phase 3 and beyond
